July 7, 2020 / 11:42 AM / a month ago

BRIEF-Theratechnologies Inc Confirms Bioequivalence Of New Tesamorelin Formulation

July 7 (Reuters) - Theratechnologies Inc:

* THERATECHNOLOGIES INC - CONFIRMS BIOEQUIVALENCE OF NEW TESAMORELIN FORMULATION

* THERATECHNOLOGIES INC - SBLA EXPECTED TO BE FILED IN EARLY 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below